BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Darunavir

An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.

298+ PubMed studies analyzed · 48 RCTs · Evidence Score: 52.5

Research Domains

Darunavir has been studied across 14 research domains including 🧠 Focus & Attention, 🫁 Liver & Detox, 🔥 Metabolic, 🦠 Gut & Microbiome, ❤️ Cardiovascular. The primary research focus is 🧠 Focus & Attention with 7% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Darunavir, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

geranylgeranylacetone
3 shared targets
Mephenesin
3 shared targets
Doripenem
4 shared targets
Carbimazole
3 shared targets
Dexamethasone
4 shared targets
Prilocaine
2 shared targets
Mefruside
2 shared targets
Guanfacine
3 shared targets
Dapsone
3 shared targets
Niceritrol
2 shared targets
Loading evidence profile...

This evidence profile for Darunavir is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.